Editorial: Assessing the Prognosis of Patients With HBV and ACLF-Comorbidities Matter. Authors' Reply.
Yu J, Chen X, Cao G, Pan Q, Huang C, Luo R, Lu X, Chen X, Li T, Huang H, Wu J, Li L, Cao H.
Yu J, et al. Among authors: lu x.
Aliment Pharmacol Ther. 2025 Jan;61(2):377-379. doi: 10.1111/apt.18392. Epub 2024 Nov 13.
Aliment Pharmacol Ther. 2025.
PMID: 39539048
No abstract available.